Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer’

被引:0
作者
J Shamash
S-J Sarker
机构
[1] St Bartholomew’s Hospital,
[2] 7th Floor,undefined
[3] Gloucester House,undefined
[4] Centre for Experimental Cancer Medicine,undefined
[5] Queen Mary University of London,undefined
来源
British Journal of Cancer | 2014年 / 110卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:266 / 267
页数:1
相关论文
共 41 条
[1]  
Omlin A(2013)Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer Br J Cancer 109 1079-1084
[2]  
Pezaro CJ(2013)Abiraterone in metastatic prostate cancer without previous chemotherapy N Engl J Med 368 138-148
[3]  
Zaidi S(2008)A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer Br J Cancer 98 22-24
[4]  
Lorentel D(2011)A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol Br J Cancer 104 620-628
[5]  
Mukherjil D(undefined)undefined undefined undefined undefined-undefined
[6]  
Bianchinil D(undefined)undefined undefined undefined undefined-undefined
[7]  
Ferraldeschil R(undefined)undefined undefined undefined undefined-undefined
[8]  
Sandhul S(undefined)undefined undefined undefined undefined-undefined
[9]  
Dearnaley D(undefined)undefined undefined undefined undefined-undefined
[10]  
Parker C(undefined)undefined undefined undefined undefined-undefined